Drug & medication recalls Moderate risk

Chlorpromazine Hydrochloride Tablets recalled over manufacturing violations

Recall date
September 3, 2025
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd.,…
Recall number
D-0633-2025
FDA classification
Class II
Brand / firm
Zydus Pharmaceuticals (USA) Inc
Sold / distributed
Nationwide in the USA

Why it was recalled

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141. NDC: 16714-048-01

Get recall alerts

Free email alert whenever Zydus Pharmaceuticals (USA) Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Zydus Pharmaceuticals (USA) Inc